Boston Partners Landec Corp \Ca\ Transaction History

Boston Partners

$77.5 Billion
Q2 2024

A detailed history of Boston Partners transactions in Landec Corp \Ca\ stock. As of the latest transaction made, Boston Partners holds 14,212 shares of LNDC stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares

14,212

Previous 19,674 27.76%

Holding current value

Previous $0 NaN%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	N/A	-5,462 Reduced 27.76%	14,212 $0
Q1 2024 May 13, 2024	BUY	N/A	19,674 New	19,674 $0
Q1 2023 May 09, 2023	SELL	N/A	-3,069 Reduced 3.18%	93,558 $0
Q4 2022 Feb 07, 2023	SELL	$0.0 - $9.95 $0 - $281,764	-28,318 Reduced 22.66%	96,627 $0
Q3 2022 Nov 09, 2022	BUY	$8.57 - $11.57 $135,680 - $183,176	15,832 Added 14.51%	124,945 $1.11 Million
Q2 2022 Aug 10, 2022	SELL	$8.84 - $11.64 $57,451 - $75,648	-6,499 Reduced 5.62%	109,113 $1.09 Million
Q1 2022 May 10, 2022	BUY	$10.07 - $11.93 $79,744 - $94,473	7,919 Added 7.35%	115,612 $1.34 Million
Q4 2021 Feb 04, 2022	BUY	$7.95 - $11.24 $201,898 - $285,451	25,396 Added 30.86%	107,693 $1.2 Million
Q3 2021 Nov 05, 2021	SELL	$9.22 - $12.44 $419,168 - $565,559	-45,463 Reduced 35.58%	82,297 $759,000
Q2 2021 Aug 12, 2021	SELL	$9.91 - $12.78 $732,041 - $944,045	-73,869 Reduced 36.64%	127,760 $1.44 Million
Q1 2021 May 10, 2021	SELL	$10.44 - $12.22 $8,633 - $10,105	-827 Reduced 0.41%	201,629 $2.14 Million
Q4 2020 Feb 04, 2021	SELL	$9.3 - $11.77 $531,820 - $673,067	-57,185 Reduced 22.02%	202,456 $2.2 Million
Q3 2020 Nov 13, 2020	SELL	$7.59 - $10.8 $259,289 - $368,949	-34,162 Reduced 11.63%	259,641 $2.52 Million
Q2 2020 Aug 12, 2020	SELL	$7.96 - $11.54 $296,892 - $430,418	-37,298 Reduced 11.26%	293,803 $2.34 Million
Q1 2020 May 13, 2020	SELL	$7.69 - $11.68 $612,946 - $930,977	-79,707 Reduced 19.4%	331,101 $2.88 Million
Q4 2019 Feb 05, 2020	BUY	$9.09 - $11.89 $496,104 - $648,920	54,577 Added 15.32%	410,808 $4.65 Million
Q3 2019 Nov 20, 2019	SELL	$9.66 - $12.36 $5.29 Million - $6.77 Million	-547,421 Reduced 60.58%	356,231 $3.87 Million
Q2 2019 Aug 09, 2019	BUY	$9.32 - $12.98 $7.85 Million - $10.9 Million	842,413 Added 1375.62%	903,652 $8.47 Million
Q1 2019 May 03, 2019	BUY	$10.35 - $13.06 $633,823 - $799,781	61,239 New	61,239 $752,000
Q3 2018 Nov 14, 2018	SELL	$12.65 - $15.15 $992,696 - $1.19 Million	-78,474 Closed	0 $0
Q2 2018 Aug 03, 2018	SELL	$13.05 - $15.45 $4.59 Million - $5.44 Million	-352,075 Reduced 81.77%	78,474 $1.17 Million
Q1 2018 May 04, 2018	BUY	$12.0 - $14.45 $567,648 - $683,542	47,304 Added 12.34%	430,549 $5.62 Million
Q4 2017 Feb 01, 2018	SELL	$11.65 - $13.35 $292,881 - $335,619	-25,140 Reduced 6.16%	383,245 $4.83 Million
Q3 2017 Nov 02, 2017	BUY	$11.95 - $13.35 $4.88 Million - $5.45 Million	408,385	408,385 $5.29 Million

Others Institutions Holding LNDC

# of Institutions

Shares Held

20.3M

Call Options Held

79.7K

Put Options Held

31.6K

View Full List

About LANDEC CORP \CA\

Ticker LNDC
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 29,595,600
Description
Landec Corporation operates as a diversified health and wellness company. The company manufactures pharmaceutical-grade sodium hyaluronate (HA)-based biomaterials for primary use in the ophthalmic and orthopedic markets. It also provides product development services to its partners for HA-based, as well as non-HA based, aseptically formulated, a...

More about LNDC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Boston Partners, based on Form 13F filings with the SEC.

News

Stay updated on Boston Partners with notifications on news.

Account